characterization protocol

Upload: itumeleng-setilo

Post on 02-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Characterization Protocol

    1/21

    Department of Medical Physics (051) 405 3156

    Characterization of small megavoltage

    photon beams for radiotherapy

    M.Med.Sc. Project Candidate: IE SETILO

    Study leader / Promoter: Dr. F.C.P du Plessis

  • 8/11/2019 Characterization Protocol

    2/21

    INTRODUCTION

    Literature fields less than 3x3 cm

    Mainly used in stereotactic radiosurgery and IMRT

    Fields provide sharp dose gradients, thus less dose spillage

    to neighbouring organs

    Inaccurate doses given for small fields

  • 8/11/2019 Characterization Protocol

    3/21

    INTRODUCTION

    Characterized by LED Lack of LEE result in decrease of dose

    Compton Effect

    =

    Detectors physical density equivalent to water

  • 8/11/2019 Characterization Protocol

    4/21

    INTRODUCTION

    Gafchromic film (EBT2)

    Small needle-like active particles (1-2m in diameter

    and 15-25m in length) composed of LiPDCA

    24 hour post-irradiation waiting period prior to scanning

    Layer

    Nominal

    thickness

    (m)

    Density

    (g/cm)

    Composition (Atom %)

    H Li C O Al

    Smooth polyester film

    base50 1.35 36.4% 0.0% 45.5% 18.2% 0.0%

    Acrylic adhesive 20 1.2 57.1% 0.0% 33.3% 9.5% 0.0%

    Active layer (assumes

    7.5% moisture)

    28 1.2 56.8% 0.6% 27.6% 13.3% 1.6%

    Smooth polyester film

    base

    175 1.35 36.4% 0.0% 45.5% 18.2% 0.0%

  • 8/11/2019 Characterization Protocol

    5/21

    INTRODUCTION

    Kodak X-omat V2 film Composed mostly of silver bromide

    Small crystals, high spatial resolution

    Strong energy dependence

    Effective atomic number of 42.6 Over respond

  • 8/11/2019 Characterization Protocol

    6/21

    INTRODUCTION

    Ionization chamber, CC01 0.01 cm volume of air, length of chamber 3.6mm with

    inner diameter of 2.0mm

    Effective atomic number > 13

    Small volume of air (less volume averaging)

    Good stability and linear response to absorbed dose

    Relatively independent of radiation direction

    Independent of beam quality-response

    Traceable to primary calibration standards

    2 mm

    Volume: 0.01 cubic centimeters

    Sensitivity: 0.0033 nC/cGy

    Active length: 3.6 mm

    Inner diameter: 2.0 mm

    Wall: C552, 0.5 mm thick, 88 mg/cm

    Electrode: steel, 0.35 mm diameter

  • 8/11/2019 Characterization Protocol

    7/21

    INTRODUCTION

    Ushielded diode (USD) High atomic number, manufactured with very small

    sensitive volumes

    Active area diameter 2.0mm, active area thickness of

    0.06mm Effective atomic number of 14

    Better penumbra measurement

    High sensitivity compared to pin point ion chamber

    Directional dependence Long-term irreversible radiation damage

    5mm

    Effective Measurement Point:

  • 8/11/2019 Characterization Protocol

    8/21

    INTRODUCTION

    EBT2 X-OMATV CC01 EFD

    Physical density 1.2 g/cm 2.3 g/cm,

    effective

    thickness

    of 0.2m

    0.001

    g/cm

    2.3 g/cm

  • 8/11/2019 Characterization Protocol

    9/21

    AIM

    Characterize small fields using different detectors atdifferent source surface distance using 6, 10 and 15MV

    photon beams

    Characterize, measure: Beam profiles (field size and Penumbra)

    Percentage depth dose curves (PDD)

    Total scatter factors (output factors)

  • 8/11/2019 Characterization Protocol

    10/21

    MATERIALS

    Linac

    Synergy S, capable of producing 6, 10 and 15MV photon

    beams at different depths (90cm, 95cm, 100cm & 150cm)

    Detectors

    Gafchromic film

    Ushielded diode

    Ionization chamber

    Kodak X-omat V2 film

  • 8/11/2019 Characterization Protocol

    11/21

    Films: Use RW3 water equivalent polystyrene plates

    (0.1mm thickness tolerance)

    Other detectors: Scanditronix/Wellhfer

    Blue Phantom Water Tank (0.5mm per axis positional

    accuracy and 0.1 mm positional reproducibility)

    MATERIALS

  • 8/11/2019 Characterization Protocol

    12/21

    STATISTICAL ANALYSIS

    Measurements will be repeated accordingly for eachdetector, in order to determine the mean and standard

    deviation of acquired results

    Accepted results for beam profile, pdd and output factorwill be the average of all four detectors

  • 8/11/2019 Characterization Protocol

    13/21

    PROGRESSION TREE

    Water tank andRW3

    measurements

    EBT2 film

    KodakXV film USD Pinpoint CC01

    chamber

    90, 95, 100 and 110cm1x1 to 5x5 cmfields

    6, 10 and 15MV

    BeamprofilesPDD

    Outputfactors

  • 8/11/2019 Characterization Protocol

    14/21

    TIME SCHEDULE

  • 8/11/2019 Characterization Protocol

    15/21

    BUDGET

    Elekta Synergy S Linac Available

    Gafchromic EBT2 film Available

    Kodak XV film **

    Ionization chamber Available

    Unshielded Diode Chamber Available but without its reference

    chamber

    Water tank Available

    RW3 Available

    Computer analysis Available

    Printing equipment Available

  • 8/11/2019 Characterization Protocol

    16/21

    STUDY LEADER: DR F.C.P DU PLESSIS Acted as examiner for the following

    PH.D. Thesis for candidate Inyang, Samuel Okon on Monte Carlo

    Simulation of Irregular Electron Fields Using EGSnrc, 2006

    M. Tech dissertation for candidate Dierdre Long on An analysis of dose

    effectiveness and incidence of lateral rectal complications of high dose-

    rate brachytherapy in the radical treatment of cervical cancer, 2007

    M. Tech dissertation for candidate Marissa Jordaan on An evaluation of

    two immobilization devices for head and neck radiation therapy at theUniversitas annex, Bloemfontein, 2008

    M. Tech dissertation for candidate B Kinsella on The development of a

    radiation quality control manual by analysing the prevalence of adverse

    indicidents during radiation therapy at the Universitas Annex,

    Bloemfontein, 2008

    PH.D. Thesis for candidate M E Sithole for the PhD defree on the The

    Effect of Silicone Gel Breast Prosthesis On Photon Dose Distributions,

    2009

  • 8/11/2019 Characterization Protocol

    17/21

    STUDY LEADER: DR F.C.P DU PLESSIS Acted as co- / study leader / promotor for the following candidates:

    D. Tech dissertation for candidate G J van der Walt on Radiation field

    shaping through low temperature thermal-spray in radiotherapy, 2009

    MSc (Med) dissertation for candidate C Trauernicht on Characterization of

    a 6 MV photon beam in terms of primary and scatter dose components,

    2009

    Mr Willie Shaw: Evaluation of a treatment planning system against Monte

    Carlo simulated 3D dose distributions. (M.Med.Sc. 20042007) Dr Kobus van der Walt: Radiation field shaping through low temperature

    thermal spray. (D Tech. 2005 - 2008)

    Dr Omer Aziz Ali: Characterization of electron beams transported through

    a photon multileaf collimator for use in optimized modulated electron

    radiation therapy procedures (Ph.D. 20072009)

    Mrs Dedri OReilly: Megavoltage image reconstruction using cone beam

    techniques. (M.Med.Sc. 20082010)

    Mr Chris Trauernicht: I131Brachytherapy seed modelling using Monte

    Carlo methods (Ph.D. 20102012)

  • 8/11/2019 Characterization Protocol

    18/21

    STUDY LEADER: DR F.C.P DU PLESSIS

    Acted as co- / study leader / promotor for the following candidates:

    Mr. Cobus Smit: Development and Validation of an X-ray Source Model

    for an Elekta Precise Multileaf Collimator to be used in Monte Carlo dose

    calculations (M.Med.Sc 2010 - 2013)

    Mrs. Dete Liebenberg: Development and Validation of an X-ray Source

    Model for an Elekta Precise Multileaf collimator to be used in Monte Carlo

    dose calculations (M.Med.Sc 2012 -present) Ms. K.R. Fourie: Electron Field Shaping through Woods alloy end-

    frames in radiotherapy, (M.Med.Sc 2011 - 2013)

    Mr. L.J. Strauss: IMRT dose verification using Monte Carlo simulations

    for a Xio TPS (M.Med.Sc 20122014)

  • 8/11/2019 Characterization Protocol

    19/21

    STUDY LEADER: DR F.C.P DU PLESSIS

    Authored & co-authored the following article publications:

    Ali, O.A., Willemse, C.A., Shaw, W., OReilly, F.H.J., du Plessis, F.C.P.,

    2011. Monte Carlo electron source model validation for an Elekta Precise

    linac. Medical Physics 38, 23662373.

    du Plessis, F.C.P., Leal, A., Stathakis, S., Xiong, W., Ma, C.-M., 2006.

    Characterization of megavoltage electron beams delivered through a

    photon multi-leaf collimator (pMLC). Physics in Medicine and Biology 51,21132129.

    du Plessis, F.C.P., Willemse, C.A., 2003. Monte Carlo calculation of

    effective attenuation coefficients for various compensator materials.

    Medical Physics 30, 25372544.

    du Plessis, F.C.P., Willemse, C.A., 2005. Radiological properties of a wax

    gypsum compensator material. Medical Physics 32, 12461255.

  • 8/11/2019 Characterization Protocol

    20/21

    STUDY LEADER: DR F.C.P DU PLESSIS

    Authored & co-authored the following article publications:

    du Plessis, F.C.P., Willemse, C.A., 2006. Inclusion of compensator-

    induced scatter and beam filtration in pencil beam dose calculations.

    Medical Physics 33, 28962904.

    du Plessis, F.C.P., Willemse, C.A., Lotter, M.G., Goedhals, L., 1998. The

    indirect use of CT numbers to establish material properties needed for

    Monte Carlo calculation of dose distributions in patients. Medical Physics25, 11951201.

    du Plessis, F.C.P., Willemse, C.A., Lotter, M.G., Goedhals, L., 2001.

    Comparison of the Batho, ETAR and Monte Carlo dose calculation

    methods in CT based patient models. Medical Physics 28, 582589.

    Fan, J., Li, J., Chen, L., Stathakis, S., Luo, W., du Plessis, F.C.P., Xiong,

    W., Yang, J., Ma, C.-M., 2006. A practical Monte Carlo MU verification

    tool for IMRT quality assurance. Physics in Medicine and Biology 51,

    25032515.

  • 8/11/2019 Characterization Protocol

    21/21